Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Leases (2019 - 2025)

Avanos Medical's Leases history spans 6 years, with the latest figure at $26.5 million for Q3 2024.

  • For Q3 2024, Leases fell 2.21% year-over-year to $26.5 million; the TTM value through Sep 2024 reached $26.5 million, down 2.21%, while the annual FY2023 figure was $26.8 million, 2.55% down from the prior year.
  • Leases for Q3 2024 was $26.5 million at Avanos Medical, down from $29.4 million in the prior quarter.
  • Across five years, Leases topped out at $60.0 million in Q2 2020 and bottomed at $24.2 million in Q1 2024.
  • The 5-year median for Leases is $33.9 million (2022), against an average of $37.6 million.
  • The largest annual shift saw Leases increased 9.11% in 2020 before it dropped 28.76% in 2022.
  • A 5-year view of Leases shows it stood at $48.3 million in 2020, then dropped by 20.08% to $38.6 million in 2021, then decreased by 28.76% to $27.5 million in 2022, then fell by 2.55% to $26.8 million in 2023, then decreased by 1.12% to $26.5 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Leases are $26.5 million (Q3 2024), $29.4 million (Q2 2024), and $24.2 million (Q1 2024).